{Reference Type}: Journal Article
{Title}: Increased rate of pancreatitis in gender diverse and transgender patients on hormone therapy: a case series study.
{Author}: Podboy A;Casey C;Buerlein RCD;Strand DS;Shami VM;Wang AY;
{Journal}: BMJ Open Gastroenterol
{Volume}: 11
{Issue}: 1
{Year}: 2024 Apr 22
暂无{DOI}: 10.1136/bmjgast-2023-001312
{Abstract}: <B>BACKGROUND: </B>There is limited data on the incidence of gastrointestinal-specific pathology in gender non-conforming (GNC) populations.<BR><B>METHODS: </B>Retrospective analysis of pancreatitis incidence rates in transgender and GNC persons exposed and not exposed to gender-affirming hormone therapy (GAHT).<BR><B>RESULTS: </B>7 of the 1333 patients on hormone therapy had an incidence of pancreatitis. 0 of the 615 patients with no history of GAHT use developed pancreatitis. Representing a 6.96 (95% CI 2.76 to 848.78) for the development of pancreatitis in patients with exposure to GAHT therapy.<BR><B>CONCLUSIONS: </B>Clinicians working with GNC individuals should be aware of this possible association.